Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids

AHMED A., (2023), Cell Reports

A 3D microtumour system that faithfully represents ovarian cancer minimal residual disease

Yang X. et al, (2023)

The role of DNA methylation in ovarian cancer chemoresistance: A narrative review.

Song K. and Artibani M., (2023), Health Sci Rep, 6

Data from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

Hu Z. et al, (2023)

Data from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

Hu Z. et al, (2023)

Supplementary Information from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

Hu Z. et al, (2023)

Supplementary Information from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

Hu Z. et al, (2023)

Table S2 from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

Hu Z. et al, (2023)

Table S2 from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

Hu Z. et al, (2023)

Single Cell Transcriptomics identifies a WNT7A-FZD5 Signaling Axis that maintains Fallopian Tube Stem Cells in Patient-derived Organoids

Alsaadi A. et al, (2022)

Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells

Artibani M. et al, (2021), JCI Insight

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct

Santana Gonzalez L. et al, (2021), Frontiers in Cellular and Infection Microbiology

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct

Santana Gonzalez L. et al, (2021), Frontiers in Cell and Developmental Biology

Promises and challenges of adoptive T-cell therapies for solid tumours

AHMED A. et al, (2021), British Journal of Cancer

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct.

Santana Gonzalez L. et al, (2021), Front Cell Dev Biol, 9

A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes.

KaramiNejadRanjbar M. et al, (2020), Elife, 9

Enhanced immunogenicity of mitochondrial localised proteins in cancer cells

CERUNDOLO V. et al, (2020), Cancer Immunology Research

An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.

Motohara T. et al, (2019), Oncogene, 38, 2885 - 2898

WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer.

McGregor RJ. et al, (2018), Br J Cancer, 119, 1508 - 1517

The Oxford Ovarian Cancer Predict Chemotherapy Response (OXO-PCR) study: Understanding the genomic drivers of primary chemotherapy-resistant microscopic residual disease

Artibani M. et al, (2018), CANCER RESEARCH, 78

Load More

Include forthcoming?